SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test
Welcome to DNA Labs UAE, where we offer the SFXN4 gene combined oxidative phosphorylation deficiency type 18 genetic test. This test is designed to diagnose individuals with a disorder characterized by a deficiency in the process of oxidative phosphorylation. Read on to learn more about the test and its components.
Test Details
The SFXN4 gene is associated with a disorder called combined oxidative phosphorylation deficiency type 18. This disorder is characterized by a deficiency in the process of oxidative phosphorylation, which is responsible for producing energy in the form of adenosine triphosphate (ATP) in cells.
The NGS genetic test for combined oxidative phosphorylation deficiency type 18 analyzes the SFXN4 gene to identify any genetic mutations or variations that may be causing the disorder. This test can help diagnose individuals with the condition and provide valuable information for treatment and management.
NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. This allows for a comprehensive analysis of the SFXN4 gene and other relevant genes, increasing the chances of identifying any genetic abnormalities.
Overall, the NGS genetic test for combined oxidative phosphorylation deficiency type 18 can help in the diagnosis and management of individuals with this disorder, providing important information for personalized treatment plans.
Test Components and Price
- Test Name: SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test
- Price: 4400.0 AED
Sample Condition
The test can be performed using blood, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test report will be delivered within 3 to 4 weeks.
Method
The test utilizes NGS technology for analysis.
Test Type
The SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test falls under the category of metabolic disorders.
Referring Doctor
The referring doctor for this test is a General Physician.
Test Department
The test is conducted in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is going for the SFXN4 gene combined oxidative phosphorylation deficiency type 18 NGS genetic DNA test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with combined oxidative phosphorylation deficiency type 18.
For more information or to schedule an appointment, please contact DNA Labs UAE.
Test Name | SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 18 |
Test Details |
The SFXN4 gene is associated with a disorder called combined oxidative phosphorylation deficiency type 18. This disorder is characterized by a deficiency in the process of oxidative phosphorylation, which is responsible for producing energy in the form of adenosine triphosphate (ATP) in cells. The NGS genetic test for combined oxidative phosphorylation deficiency type 18 analyzes the SFXN4 gene to identify any genetic mutations or variations that may be causing the disorder. This test can help diagnose individuals with the condition and provide valuable information for treatment and management. NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. This allows for a comprehensive analysis of the SFXN4 gene and other relevant genes, increasing the chances of identifying any genetic abnormalities. Overall, the NGS genetic test for combined oxidative phosphorylation deficiency type 18 can help in the diagnosis and management of individuals with this disorder, providing important information for personalized treatment plans. |